Off Label Use Of High Cost Drugs To Make Fat People Skinny Again

New Drugs for Weight Loss: What Plan Sponsors Need to Know

By Eileen O. Pincay, RPh

The latest generation of prescription drugs originally developed to help people manage their type 2 diabetes have been causing quite a stir for patients, health professionals and benefit plans, now that they’ve been approved and are being promoted to treat weight loss. Health benefit plan sponsors who are presently excluding weight-loss drugs from coverage are revisiting coverage rules because of the effectiveness and demand for these newer weight-loss drugs.

Continue reading Off Label Use Of High Cost Drugs To Make Fat People Skinny Again

Centivo’s 2022 Healthcare Spend Analysis Reveals 21 to 33 Percent Cost Savings for Employers

Employees Using Centivo Also Visited Primary Care Physicians More and Experienced Fewer Emergency and Inpatient Visits Than Industry Benchmarks

BUFFALO, N.Y. — Centivo, a new type of health plan for self-funded employers anchored around leading providers of value-based care, today announced key findings from its 2022 healthcare spend analysis derived from the Company’s flagship Partnership Plan offering. The findings reveal dramatic healthcare cost savings for Centivo’s employer clients (21 to 33 percent) compared to widely recognized industry benchmarks.

Continue reading Centivo’s 2022 Healthcare Spend Analysis Reveals 21 to 33 Percent Cost Savings for Employers